AbCellera Biologics Inc. announced consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported total revenue was USD 27,643,000 compared to USD 11,228,000 a year ago. Loss from operations was USD 7,033,000 compared to loss of USD 854,000 a year ago. Net loss was USD 2,323,000 compared to profit of USD 6,703,000 a year ago. Net loss per share attributable to common shareholders was USD 0.01 per basic share compared to net earnings of USD 0.03 per basic share a year ago. For the six months, the company reported total revenue was USD 230,384,000 compared to USD 15,885,000 a year ago. Income from operations was USD 150,975,000 compared to loss of USD 2,976,000 a year ago. Net earnings was USD 114,898,000 compared to earnings of USD 4,610,000 a year ago. Net earnings per share attributable to common shareholders was USD 0.42 per basic share compared to USD 0.02 per basic share a year ago. Net earnings per share attributable to common shareholders was USD 0.36 per diluted share compared to USD 0.02 per diluted share a year ago.